Kathrin Koch

1PUBLICATIONS
7CO-AUTHORS
Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 27, 2022
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.

Claudia Janoschka, Maren Lindner, Nils Koppers

Pageof 1